Biogen, Inc. (BIIB)
192.95
+1.58
(+0.83%)
USD |
NASDAQ |
May 15, 16:00
190.35
-2.60
(-1.35%)
After-Hours: 07:12
Biogen Research and Development Expense (Quarterly) : 471.10M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.719B |
| Gilead Sciences, Inc. | 1.354B |
| AbbVie, Inc. | 2.472B |
| Apellis Pharmaceuticals, Inc. | 76.96M |
| Moderna, Inc. | 590.00M |